EPO Patents = 4

Trademarks = 1

Forward Citations = 0

Loading Chart...

6 inventors (with patents filed for the assignee):

Wenjin Yang (5 out of 37 patents)

Kai-Wei Chang (3 out of 6 patents)

Suying Liu (3 out of 3 patents)

4. Kai-Wei Chang (2 out of 2 patents)

5. Cheng-Han Tsai (2 out of 2 patents)

6. Cheng-Han Tsai (1 out of 18 patents)

5 patents: Sort by Forward Citations

1. 12583844 - Matrix metalloproteinase (MMP) inhibitors and methods of use thereof (2026-03-24),

2. 12503460 - Matrix metalloproteinase (MMP) inhibitors and methods of use thereof (2025-12-23),

3. 12258335 - Matrix metalloproteinase (MMP) inhibitors and methods of use thereof (2025-03-25),

4. 12215096 - Matrix metalloproteinase (MMP) inhibitors and methods of use thereof (2025-02-04),

5. 11739080 - Matrix metalloproteinase (MMP) inhibitors and methods of use thereof (2023-08-29),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#48 in Newark, DE

#737 in Delaware

#51,644 in US

Newark, DE, United States of America

Foresee Pharmaceuticals USA, Inc.

Forward Citations = 0

6 inventors:

Wenjin Yang (5 out of 37 patents)

Kai-Wei Chang (3 out of 6 patents)

Suying Liu (3 out of 3 patents)

4. Kai-Wei Chang (2 out of 2 patents)

5. Cheng-Han Tsai (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Foresee Pharmaceuticals USA, Inc.. Retrieved from https://idiyas.com/company/foresee-pharmaceuticals-usa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]